Canada Startup Newsletter – 16 December
This week we present another edition of our Canadian Startup Newsletter, the final one of the year. Featured are two very different companies providing extremely unique solutions.
First, we have a company developing a drug attempting to fight cancer while another is enabling business executives to be better public speakers.
Pacylex Pharmaceuticals is a Canadian company developing an oral small molecule drug, PCLX-001, as a first-in-class therapy for a new target in cancer, myristoylation.
OutLoud Speakers School
OutLoud Speakers School is a training and development company specializing in public speaking, content creation, virtual communication skills, and pitch coaching for founders and their teams.